CPSF1 and prostate carcinoma: Our work showing that CPSF1-regulated genes are targets of JTE-607, but not all targets of JTE-607 are regulated by CPSF1, indicates that applying strategies to develop or identify CPSF1-specific inhibitors could yield attractive, and perhaps more specific, therapeutic candidates for prostate cancer.